AORT logo

AORT
Artivion Inc

332
Mkt Cap
$1.11B
Volume
159,005.00
52W High
$48.25
52W Low
$19.16
PE Ratio
94.84
AORT Fundamentals
Price
$22.32
Prev Close
$22.77
Open
$22.85
50D MA
$33.68
Beta
0.84
Avg. Volume
408,110.64
EPS (Annual)
$0.2069
P/B
2.45
Rev/Employee
$245,183.33
$2,344.66
Loading...
Loading...
News
all
press releases
Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS Aortic Arch System
Endospan, a pioneer in endovascular solutions for complex aortic pathologies, today announced that Artivion, Inc. (NYSE: AORT) has closed the transaction to acquire the company. This strategic...
News Placeholder
More News
News Placeholder
Artivion Completes Acquisition of Endospan Ltd.
Artivion Completes Acquisition of Endospan Ltd. Artivion Completes Acquisition of Endospan Ltd. PR Newswire ATLANTA, May 18, 2026 ATLANTA, May 18, 2026 Artivion, Inc. (NYSE: AORT), a leading cardiac...
News Placeholder
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Artivion, Inc.
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Artivion, Inc. Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Artivion, Inc. PR Newswire...
News Placeholder
Crude Oil Gains 1%; Fluor Shares Plunge After Q1 Results
US stocks traded higher, Nasdaq gained 1.5%. Dow down 0.06%. IT shares up 2.1% while healthcare stocks fell 0.9%. Fluor shares dropped 12% due to weak earnings. Westrock Coffee, Innodata, and Nlight...
News Placeholder
Artivion (AORT) Q1 Earnings and Revenues Surpass Estimates
Artivion (AORT) delivered earnings and revenue surprises of +33.33% and +0.33%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Artivion (AORT) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
News Placeholder
Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan
Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to...
News Placeholder
Artivion, Inc. (NYSE:AORT) Sees Large Growth in Short Interest
Artivion, Inc. (NYSE:AORT - Get Free Report) was the target of a large growth in short interest during the month of April. As of April 15th, there was short interest totaling 1,943,835 shares, a growth of 16.6% from the March 31st total of 1,667,100 shares. Currently, 4.3% of the shares of the...
News Placeholder
Artivion (AORT) to Release Quarterly Earnings on Thursday
Artivion (NYSE:AORT) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at...
News Placeholder
Artivion (NYSE:AORT) Downgraded to "Hold" Rating by Wall Street Zen
Wall Street Zen downgraded Artivion from a "buy" rating to a "hold" rating in a research report on Saturday...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available